☰

Kelly A. Metcalfe, Ph.D. - Publications

Affiliations: 
2002 University of Toronto, Toronto, ON, Canada 
Area:
Medicine and Surgery, Oncology
Tree Info Similar researchers PubMed Report error

150/187 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Narod SA, Metcalfe K, Finch A, Chan AW, Armel SR, Aeilts A, Eisen A, Karlan B, Bordeleau L, Tung N, Foulkes WD, Neuhausen SL, Eng C, Olopade O, Zakalik D, et al. The risk of skin cancer in women who carry BRCA1 or BRCA2 mutations. Hereditary Cancer in Clinical Practice. 22: 7. PMID 38741145 DOI: 10.1186/s13053-024-00277-5  0.577
2024 Kotsopoulos J, Gronwald J, Huzarski T, Møller P, Pal T, McCuaig JM, Singer CF, Karlan BY, Aeilts A, Eng C, Eisen A, Bordeleau L, Foulkes WD, Tung N, Couch FJ, ... ... Metcalfe K, et al. Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations. Jama Oncology. PMID 38421677 DOI: 10.1001/jamaoncol.2023.6937  0.566
2024 Lubinski J, Kotsopoulos J, Moller P, Pal T, Eisen A, Peck L, Karlan BY, Aeilts A, Eng C, Bordeleau L, Foulkes WD, Tung N, Couch FJ, Fruscio R, Ramon Y Cajal T, ... ... Metcalfe K, et al. MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence Variations. Jama Oncology. PMID 38421676 DOI: 10.1001/jamaoncol.2023.6944  0.635
2023 Metcalfe K, Huzarski T, Gronwald J, Kotsopoulos J, Kim R, Moller P, Pal T, Aeilts A, Eisen A, Karlan B, Bordeleau L, Tung N, Olopade O, Zakalik D, Singer CF, et al. Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis. British Journal of Cancer. PMID 38030749 DOI: 10.1038/s41416-023-02503-8  0.674
2023 Metcalfe KA, Pal T, Narod SA, Armel S, Shickh S, Buckley K, Walters ST, Brennenstuhl S, Kinney AY. Theory-based behavior change intervention to increase uptake of risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 pathogenic variant: The PREVENT randomized controlled trial. Cancer Medicine. PMID 37602539 DOI: 10.1002/cam4.6417  0.483
2023 Kotsopoulos J, Gronwald J, Huzarski T, Aeilts A, Randall Armel S, Karlan B, Singer CF, Eisen A, Tung N, Olopade O, Bordeleau L, Eng C, Foulkes WD, Neuhausen SL, Cullinane CA, ... ... Metcalfe K, et al. Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation. Breast Cancer Research and Treatment. 201: 257-264. PMID 37432545 DOI: 10.1007/s10549-023-06991-3  0.713
2023 Evans DG, Phillips KA, Milne RL, Fruscio R, Cybulski C, Gronwald J, Lubinski J, Huzarski T, Hyder Z, Forde C, Metcalfe K, Senter L, Weitzel J, Tung N, Zakalik D, et al. Correction to: Survival from breast cancer in women with a BRCA2 mutation by treatment. British Journal of Cancer. PMID 36639528 DOI: 10.1038/s41416-022-02130-9  0.688
2022 Metcalfe KA, Gronwald J, Tung NM, McCuaig JM, Eisen A, Elser C, Foulkes WD, Neuhausen SL, Senter L, Moller P, Bordeleau L, Fruscio R, Velsher L, Zakalik D, Olopade OI, et al. The risks of cancer in older women with BRCA pathogenic variants: How far have we come? Cancer. PMID 36571512 DOI: 10.1002/cncr.34615  0.606
2022 Metcalfe KA, Narod SA, Eisen A, Poll A, Zamani N, McCready D, Cil TD, Wright FC, Lerner-Ellis J, McCuaig J, Graham T, Sun P, Akbari MR. Genetic testing women with newly diagnosed breast cancer: What criteria are the most predictive of a positive test? Cancer Medicine. PMID 36544278 DOI: 10.1002/cam4.5515  0.604
2022 Tindale LC, Zhantuyakova A, Lam S, Woo M, Kwon JS, Hanley GE, Knoppers B, Schrader KA, Peacock SJ, Talhouk A, Dummer T, Metcalfe K, Pashayan N, Foulkes WD, Manchanda R, et al. Gynecologic Cancer Risk and Genetics: Informing an Ideal Model of Gynecologic Cancer Prevention. Current Oncology (Toronto, Ont.). 29: 4632-4646. PMID 35877228 DOI: 10.3390/curroncol29070368  0.419
2022 Carlsson L, Thain E, Gillies B, Metcalfe K. Psychological and health behaviour outcomes following multi-gene panel testing for hereditary breast and ovarian cancer risk: a mini-review of the literature. Hereditary Cancer in Clinical Practice. 20: 25. PMID 35733200 DOI: 10.1186/s13053-022-00229-x  0.412
2022 Kotsopoulos J, Lubiński J, Gronwald J, Menkiszak J, McCuaig J, Metcalfe K, Foulkes WD, Neuhausen SL, Sun S, Karlan BY, Eisen A, Tung N, Olopade OI, Couch FJ, Huzarski T, et al. Bilateral Oophorectomy and the Risk of Breast Cancer in BRCA1 Mutation Carriers: a Reappraisal. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 35477169 DOI: 10.1158/1055-9965.EPI-21-1196  0.681
2022 Howell DM, Metcalfe K, Kong S, Stephen J, Olivotto IA, Baxter N, Friedenreich CM, Warner E, Akbari MR, McBain K, Narod S, Quan ML. Risk factors for psychological morbidity and the protective role of coping self-efficacy in young women with breast cancer early in diagnosis: a national multicentre cohort study. Breast Cancer Research and Treatment. PMID 35462611 DOI: 10.1007/s10549-022-06576-6  0.586
2022 McCuaig JM, Ferguson SE, Vicus D, Ott K, Stockley TL, Kim RH, Metcalfe KA. Reflex BRCA1 and BRCA2 tumour genetic testing for high-grade serous ovarian cancer: streamlined for clinicians but what do patients think? Hereditary Cancer in Clinical Practice. 20: 15. PMID 35418215 DOI: 10.1186/s13053-022-00221-5  0.357
2022 Carmona CA, Yee S, Seminsky M, Glass K, Foong S, Lipson E, Baxter NN, Friedenreich CM, Metcalfe K, Isherwood S, Akbari MR, Narod S, Quan ML, Warner E. ASO Visual Abstract: Surgeon and Patient Reports of Fertility Preservation Referral and Uptake in a Prospective Pan-Canadian Study of Young Women with Breast Cancer. Annals of Surgical Oncology. PMID 35166950 DOI: 10.1245/s10434-022-11340-7  0.618
2022 Carmona CA, Yee S, Seminsky M, Glass K, Foong S, Lipson E, Baxter NN, Friedenreich CM, Metcalfe K, Isherwood S, Akbari MR, Narod S, Quan ML, Warner E. Surgeon and Patient Reports of Fertility Preservation Referral and Uptake in a Prospective, Pan-Canadian Study of Young Women with Breast Cancer. Annals of Surgical Oncology. PMID 35001240 DOI: 10.1245/s10434-021-11254-w  0.665
2021 Finch A, Metcalfe K, Akbari M, Friedman E, Tung N, Rosen B, Eisen A, Karlan B, Foulkes W, Neuhausen SL, Senter L, McKinnon W, Elser C, Sun P, Narod SA. The Risks of Breast and Ovarian Cancer Associated with the Ashkenazi Jewish Founder Allele BRCA2 6174delT. Clinical Genetics. PMID 34897671 DOI: 10.1111/cge.14098  0.679
2021 Dossa F, Metcalfe K, Sutradhar R, Little T, Eisen A, Chun K, Meschino WS, Velsher L, Ellis JL, Baxter NN. Building the What Comes Next Cohort for and testing: a descriptive analysis. Cmaj Open. 9: E874-E885. PMID 34870614 DOI: 10.9778/cmajo.20200228  0.386
2021 Metcalfe KA, Eisen A, Wright F, Poll A, Candib A, McCready D, Cil T, Armel S, Silberman Y, Brennenstuhl S, Narod SA. Impact of rapid genetic testing for BRCA1 and BRCA2 at time of breast cancer diagnosis on psychosocial functioning. Breast Cancer Research and Treatment. 191: 631-641. PMID 34846626 DOI: 10.1007/s10549-021-06457-4  0.681
2021 Zhong T, Mahajan A, Cowan K, Temple-Oberle C, Porter G, LeBlanc M, Metcalfe K. Identifying the top research priorities in postmastectomy breast cancer reconstruction: a James Lind Alliance priority setting partnership. Bmj Open. 11: e047589. PMID 34462280 DOI: 10.1136/bmjopen-2020-047589  0.418
2021 Lim DW, Metcalfe KA. ASO Author Reflections: Psychosocial Outcomes After Breast Cancer Treatment. Annals of Surgical Oncology. PMID 33950312 DOI: 10.1245/s10434-021-10017-x  0.443
2021 Narod SA, Gojska N, Sun P, Tryon A, Kotsopoulos J, Metcalfe K, Akbari MR. The Screen Project: Guided Direct-To-Consumer Genetic Testing for Breast Cancer Susceptibility in Canada. Cancers. 13. PMID 33920818 DOI: 10.3390/cancers13081894  0.609
2021 Lim DW, Retrouvey H, Kerrebijn I, Butler K, O'Neill AC, Cil TD, Zhong T, Hofer SOP, McCready DR, Metcalfe KA. ASO Visual Abstract: Longitudinal Study of Psychosocial Outcomes Following Surgery in Women with Unilateral Nonhereditary Breast Cancer. Annals of Surgical Oncology. PMID 33876350 DOI: 10.1245/s10434-021-10008-y  0.465
2021 Lim DW, Retrouvey H, Kerrebijn I, Butler K, O'Neill AC, Cil TD, Zhong T, Hofer SOP, McCready DR, Metcalfe KA. Longitudinal Study of Psychosocial Outcomes Following Surgery in Women with Unilateral Nonhereditary Breast Cancer. Annals of Surgical Oncology. PMID 33821345 DOI: 10.1245/s10434-021-09928-6  0.547
2021 Metcalfe KA, Eisen A, Poll A, Candib A, McCready D, Cil T, Wright F, Demsky R, Mancuso T, Sun P, Narod SA. Frequency of Contralateral Prophylactic Mastectomy in Breast Cancer Patients with a Negative BRCA1 and BRCA2 Rapid Genetic Test Result. Annals of Surgical Oncology. PMID 33761021 DOI: 10.1245/s10434-021-09855-6  0.691
2021 Evans DG, Phillips KA, Milne RL, Fruscio R, Cybulski C, Gronwald J, Lubinski J, Huzarski T, Hyder Z, Forde C, Metcalfe K, Senter L, Weitzel J, Tung N, Zakalik D, et al. Survival from breast cancer in women with a BRCA2 mutation by treatment. British Journal of Cancer. PMID 33597716 DOI: 10.1038/s41416-020-01164-1  0.672
2021 Lim DW, Metcalfe KA, Narod SA. Bilateral Mastectomy in Women With Unilateral Breast Cancer: A Review. Jama Surgery. PMID 33566074 DOI: 10.1001/jamasurg.2020.6664  0.671
2020 Metcalfe KA, Candib A, Giannakeas V, Eisen A, Poll A, McCready D, Cil T, Wright FC, Armel S, Ott K, Sun P, Narod SA. The relationship between the predicted risk of death and psychosocial functioning among women with early-stage breast cancer. Breast Cancer Research and Treatment. PMID 33174180 DOI: 10.1007/s10549-020-05992-w  0.663
2020 Mansfield CA, Metcalfe KA, Snyder C, Lindeman GJ, Posner J, Friedman S, Lynch HT, Narod SA, Evans DG, Liede A. Preferences for breast cancer prevention among women with a or mutation. Hereditary Cancer in Clinical Practice. 18: 20. PMID 33014209 DOI: 10.1186/s13053-020-00152-z  0.718
2020 Metcalfe KA, Eisen A, Poll A, Candib A, McCready D, Cil T, Wright F, Lerner-Ellis J, McCuaig J, Graham T, Sun P, Akbari M, Narod SA. Rapid Genetic Testing for BRCA1 and BRCA2 Mutations at the Time of Breast Cancer Diagnosis: An Observational Study. Annals of Surgical Oncology. PMID 32989658 DOI: 10.1245/s10434-020-09160-8  0.714
2020 McCuaig JM, Care M, Ferguson SE, Kim RH, Stockley TL, Metcalfe KA. Year 1: Experiences of a tertiary cancer centre following implementation of reflex BRCA1 and BRCA2 tumor testing for all high-grade serous ovarian cancers in a universal healthcare system. Gynecologic Oncology. PMID 32674931 DOI: 10.1016/J.Ygyno.2020.06.507  0.457
2020 Metcalfe KA, Price MA, Mansfield C, Hallett DC, Lindeman GJ, Fairchild A, Posner J, Friedman S, Snyder C, Lynch HT, Evans DG, Narod SA, Liede A. Predictors of long-term cancer-related distress among female BRCA1 and BRCA2 mutation carriers without a cancer diagnosis: an international analysis. British Journal of Cancer. PMID 32393849 DOI: 10.1038/S41416-020-0861-3  0.721
2020 Barker LC, Dennis CL, Hussain-Shamsy N, Stewart DE, Grigoriadis S, Metcalfe K, Oberlander TF, Schram C, Taylor VH, Vigod SN. Decision-making about antidepressant medication use in pregnancy: a comparison between women making the decision in the preconception period versus in pregnancy. Bmc Psychiatry. 20: 54. PMID 32033547 DOI: 10.1186/S12888-020-2478-8  0.302
2020 Lim DW, Retrouvey H, Kerrebijn I, Butler K, O'Neill AC, Cil T, Zhong T, Hofer S, McCready DR, Metcalfe KA. Psychosocial outcomes following surgery in women with unilateral, nonhereditary breast cancer. Journal of Clinical Oncology. 38: 570-570. DOI: 10.1200/Jco.2020.38.15_Suppl.570  0.638
2019 Galica J, Maheu C, Brennenstuhl S, Townsley C, Metcalfe K. Examining Predictors of Fear of Cancer Recurrence Using Leventhal's Commonsense Model: Distinct Implications for Oncology Nurses. Cancer Nursing. PMID 31868820 DOI: 10.1097/Ncc.0000000000000760  0.359
2019 Yang X, Leslie G, Doroszuk A, Schneider S, Allen J, Decker B, Dunning AM, Redman J, Scarth J, Plaskocinska I, Luccarini C, Shah M, Pooley K, Dorling L, Lee A, ... ... Metcalfe K, et al. Cancer Risks Associated With Germline Pathogenic Variants: An International Study of 524 Families. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1901907. PMID 31841383 DOI: 10.1200/Jco.19.01907  0.545
2019 Speller B, Metcalfe K, Kennedy ED, Facey M, Greenblatt E, Scheer AS, Warner E, Joy AA, Wright FC, Baxter NN. The "Begin Exploring Fertility Options, Risks and Expectations" (BEFORE) decision aid: development and alpha testing of a fertility tool for premenopausal breast cancer patients. Bmc Medical Informatics and Decision Making. 19: 203. PMID 31660965 DOI: 10.1186/S12911-019-0912-Y  0.51
2019 Metcalfe KA, Retrouvey H, Kerrebijn I, Butler K, O'Neill AC, Cil T, Zhong T, Hofer SOP, McCready DR. Predictors of uptake of contralateral prophylactic mastectomy in women with nonhereditary breast cancer. Cancer. PMID 31435939 DOI: 10.1002/Cncr.32405  0.661
2019 Moran O, Eisen A, Demsky R, Blackmore K, Knight JA, Panchal S, Ginsburg O, Zbuk K, Yaffe M, Metcalfe KA, Narod SA, Kotsopoulos J. Predictors of mammographic density among women with a strong family history of breast cancer. Bmc Cancer. 19: 631. PMID 31242899 DOI: 10.1186/S12885-019-5855-2  0.704
2019 Retrouvey H, Kerrebijn I, Metcalfe KA, O'Neill AC, McCready DR, Hofer SOP, Zhong T. Psychosocial Functioning in Women with Early Breast Cancer Treated with Breast Surgery With or Without Immediate Breast Reconstruction. Annals of Surgical Oncology. PMID 31062209 DOI: 10.1245/S10434-019-07251-9  0.576
2019 Metcalfe K, Eisen A, Senter L, Armel S, Bordeleau L, Meschino WS, Pal T, Lynch HT, Tung NM, Kwong A, Ainsworth P, Karlan B, Moller P, Eng C, Weitzel JN, et al. International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation. British Journal of Cancer. PMID 30971774 DOI: 10.1038/S41416-019-0446-1  0.719
2019 Speller B, Sissons A, Daly C, Facey M, Kennedy E, Metcalfe K, Baxter NN. An evaluation of oncofertility decision support resources among breast cancer patients and health care providers. Bmc Health Services Research. 19: 101. PMID 30728004 DOI: 10.1186/S12913-019-3901-Z  0.465
2019 Metcalfe K, Lynch HT, Foulkes WD, Tung N, Olopade OI, Eisen A, Lerner-Ellis J, Snyder C, Kim SJ, Sun P, Narod SA. Oestrogen receptor status and survival in women with BRCA2-associated breast cancer. British Journal of Cancer. PMID 30723304 DOI: 10.1038/S41416-019-0376-Y  0.725
2019 Metcalfe KA, Poll A, Eisen A, Lerner-Ellis J, Narod S. Outcomes associated with rapid genetic testing for BRCA1 and BRCA2 at time of breast cancer diagnosis. Journal of Clinical Oncology. 37: 1577-1577. DOI: 10.1200/Jco.2019.37.15_Suppl.1577  0.699
2019 Dossa F, Little T, Metcalfe K, Sutradhar R, Lerner-Ellis J, Meschino W, Eisen A, Baxter NN. What Comes Next? A Cohort Profile of Women Who Have Undergone BRCA1 and BRCA2 Testing in Ontario, Canada Journal of the American College of Surgeons. 229. DOI: 10.1016/J.Jamcollsurg.2019.08.937  0.524
2018 McCuaig JM, Armel SR, Care M, Volenik A, Kim RH, Metcalfe KA. Next-Generation Service Delivery: A Scoping Review of Patient Outcomes Associated with Alternative Models of Genetic Counseling and Genetic Testing for Hereditary Cancer. Cancers. 10. PMID 30428547 DOI: 10.3390/Cancers10110435  0.329
2018 Hall E, Finch A, Jacobson M, Rosen B, Metcalfe K, Sun P, Narod SA, Kotsopoulos J. Effects of bilateral salpingo-oophorectomy on menopausal symptoms and sexual functioning among women with a BRCA1 or BRCA2 mutation. Gynecologic Oncology. PMID 30414741 DOI: 10.1016/J.Ygyno.2018.10.040  0.587
2018 Ahmed H, Lerner-Ellis J, Cybulski C, Metcalfe K, Lubiński J, Narod SA, Akbari MR. Reply to 'Mutations in RECQL are not associated with breast cancer risk in an Australian population'. Nature Genetics. PMID 30224648 DOI: 10.1038/S41588-018-0233-6  0.686
2018 Dossa F, Cusimano MC, Sutradhar R, Metcalfe K, Little T, Lerner-Ellis J, Eisen A, Meschino WS, Baxter NN. Real-world health services utilisation and outcomes after and testing in Ontario, Canada: the What Comes Next Cohort Study protocol. Bmj Open. 8: e025317. PMID 30181190 DOI: 10.1136/Bmjopen-2018-025317  0.588
2018 Galica J, Brennenstuhl S, Maheu C, Townsley C, Metcalfe K. Examining the dimensionality of the Fear of Cancer Recurrence Inventory. Psycho-Oncology. PMID 29998546 DOI: 10.1002/Pon.4839  0.444
2018 Mor P, Brennenstuhl S, Metcalfe KA. Uptake of Preimplantation Genetic Diagnosis in Female BRCA1 and BRCA2 Mutation Carriers. Journal of Genetic Counseling. PMID 29858758 DOI: 10.1007/S10897-018-0264-2  0.678
2018 Metcalfe K, Akbari MR, Narod SA. Genetic testing for young women with breast cancer. The Lancet. Oncology. 19: e182. PMID 29611519 DOI: 10.1016/S1470-2045(18)30162-1  0.714
2017 Metcalfe KA, Lubinski J, Gronwald J, Huzarski T, McCuaig J, Lynch HT, Karlan B, Foulkes WD, Singer CF, Neuhausen SL, Senter L, Eisen A, Sun P, Narod SA. The Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers without a First-Degree Relative with Breast Cancer. Clinical Genetics. PMID 29206279 DOI: 10.1111/Cge.13191  0.739
2017 Metcalfe K, Zhong T, O'Neill AC, McCready D, Chan L, Butler K, Brennenstuhl S, Hofer SOP. Development and testing of a decision aid for women considering delayed breast reconstruction. Journal of Plastic, Reconstructive & Aesthetic Surgery : Jpras. PMID 28958567 DOI: 10.1016/J.Bjps.2017.08.027  0.497
2017 McInerney NM, Narod S, Metcalfe K, Semple J, Brown MH. Breast Cancer Genetics for Plastic Surgeons. Plastic and Reconstructive Surgery. 140: 455-460. PMID 28841602 DOI: 10.1097/Prs.0000000000003577  0.624
2017 Liede A, Mansfield CA, Metcalfe KA, Price MA, Snyder C, Lynch HT, Friedman S, Amelio J, Posner J, Narod SA, Lindeman GJ, Evans DG. Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment. Breast Cancer Research and Treatment. PMID 28624978 DOI: 10.1007/S10549-017-4332-3  0.712
2017 L Semple J, Metcalfe K, Shoukat F, Sun P, Narod S. Survival Differences in Women with and without Autologous Breast Reconstruction after Mastectomy for Breast Cancer. Plastic and Reconstructive Surgery. Global Open. 5: e1281. PMID 28507852 DOI: 10.1097/Gox.0000000000001281  0.667
2017 Metcalfe KA, Semple J, Quan ML, Holloway C, Wright F, Narod S, Hofer S, Bagher S, Zhong T. Why Some Mastectomy Patients Opt to Undergo Delayed Breast Reconstruction: Results of a Long-Term Prospective Study. Plastic and Reconstructive Surgery. 139: 267-275. PMID 28121851 DOI: 10.1097/Prs.0000000000002943  0.602
2017 Kotsopoulos J, Huzarski T, Gronwald J, Singer CF, Moller P, Lynch HT, Armel S, Karlan B, Foulkes WD, Neuhausen SL, Senter L, Tung N, Weitzel JN, Eisen A, Metcalfe K, et al. Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. Journal of the National Cancer Institute. 109. PMID 27601060 DOI: 10.1093/Jnci/Djw177  0.714
2017 Speller B, Facey M, Sissons A, Daly C, Kennedy ED, Metcalfe KA, Baxter NN. Development of a decision aid for young canadians diagnosed with breast cancer who are at risk of infertility following cancer treatment. Journal of Clinical Oncology. 35: 108-108. DOI: 10.1200/Jco.2017.35.5_Suppl.108  0.563
2017 Metcalfe KA, Akbari MR, Narod S, Lerner-Ellis J. PALB2 mutations in high-risk women with breast or ovarian cancer. Journal of Clinical Oncology. 35: 1527-1527. DOI: 10.1200/Jco.2017.35.15_Suppl.1527  0.763
2017 Moran OM, Nikitina D, Gunasekara A, Yaffe MJ, Metcalfe KA, Narod SA, Kotsopoulos J. Abstract B12: The effect of physical activity and body size on mammographic density in high-risk, BRCA mutation-negative women Cancer Epidemiology and Prevention Biomarkers. 26. DOI: 10.1158/1538-7755.Carisk16-B12  0.673
2017 Liede A, Evans G, Metcalfe K, Price M, Snyder C, Lynch H, Friedman S, Amelio J, Posner J, Lindeman G, Mansfield C. Abstract P3-08-08: Preferences for breast cancer risk reduction amongBRCA1andBRCA2mutation carriers: A discrete choice experiment Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P3-08-08  0.566
2016 Moran O, Nikitina D, Royer R, Poll A, Metcalfe K, Narod SA, Akbari MR, Kotsopoulos J. Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panel. Breast Cancer Research and Treatment. PMID 27798748 DOI: 10.1007/S10549-016-4038-Y  0.725
2016 Zhong T, Hu J, Bagher S, Vo A, OʼNeill AC, Butler K, Novak CB, Hofer SO, Metcalfe KA. A Comparison of Psychological Response, Body Image, Sexuality, and Quality of Life between Immediate and Delayed Autologous Tissue Breast Reconstruction: A Prospective Long-Term Outcome Study. Plastic and Reconstructive Surgery. 138: 772-780. PMID 27673514 DOI: 10.1097/Prs.0000000000002536  0.403
2016 Metcalfe KA, Dennis CL, Poll A, Armel S, Demsky R, Carlsson L, Nanda S, Kiss A, Narod SA. Effect of decision aid for breast cancer prevention on decisional conflict in women with a BRCA1 or BRCA2 mutation: a multisite, randomized, controlled trial. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 27584910 DOI: 10.1038/Gim.2016.108  0.742
2016 Vigod S, Hussain-Shamsy N, Grigoriadis S, Howard LM, Metcalfe K, Oberlander TF, Schram C, Stewart DE, Taylor VH, Dennis CL. A patient decision aid for antidepressant use in pregnancy: study protocol for a randomized controlled trial. Trials. 17: 110. PMID 26923796 DOI: 10.1186/S13063-016-1233-4  0.303
2016 Metcalfe KA, Narod S, Eisen A, Lerner-Ellis J. Treatment decision making and psychosocial outcomes associated with rapid genetic testing for BRCA1 and BRCA2 in women newly diagnosed with breast cancer. Journal of Clinical Oncology. 34: 1586-1586. DOI: 10.1200/Jco.2016.34.15_Suppl.1586  0.672
2016 Liede A, Fairchild A, Friedman S, Amelio J, Hallett D, Mansfield C, Metcalfe K. Abstract P2-09-09: Risk-reducing surgery and cancer-related distress among femaleBRCA1andBRCA2mutation carriers: Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P2-09-09  0.673
2015 Semple J, Metcalfe KA, Lubinski J, Huzarski T, Gronwald J, Armel S, Lynch HT, Karlan B, Foulkes W, Singer CF, Neuhausen SL, Eng C, Iqbal J, Narod SA. Does the age of breast cancer diagnosis in first-degree relatives impact on the risk of breast cancer in BRCA1 and BRCA2 mutation carriers? Breast Cancer Research and Treatment. 154: 163-9. PMID 26467043 DOI: 10.1007/S10549-015-3596-8  0.75
2015 Metcalfe KA, Eisen A, Lerner-Ellis J, Narod SA. Is it time to offer BRCA1 and BRCA2 testing to all Jewish women? Current Oncology (Toronto, Ont.). 22: e233-6. PMID 26300672 DOI: 10.3747/Co.22.2527  0.52
2015 Finch A, Wang M, Fine A, Atri L, Khalouei S, Pupavac M, Rosen B, Eisen A, Elser C, Charames G, Metcalfe K, Chang MC, Narod SA, Lerner-Ellis J. Genetic testing for BRCA1 and BRCA2 in the Province of Ontario. Clinical Genetics. PMID 26219728 DOI: 10.1111/Cge.12647  0.662
2015 Metcalfe KA, Cil TD, Semple JL, Li LD, Bagher S, Zhong T, Virani S, Narod S, Pal T. Long-Term Psychosocial Functioning in Women with Bilateral Prophylactic Mastectomy: Does Preservation of the Nipple-Areolar Complex Make a Difference? Annals of Surgical Oncology. PMID 26208581 DOI: 10.1245/S10434-015-4761-3  0.678
2015 Metcalfe K, Lynch HT, Foulkes WD, Tung N, Kim-Sing C, Olopade OI, Eisen A, Rosen B, Snyder C, Gershman S, Sun P, Narod SA. Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers. Jama Oncology. 1: 306-13. PMID 26181175 DOI: 10.1001/Jamaoncol.2015.0658  0.755
2015 Snyder C, Metcalfe K, Sopik V, Royer R, Zhang S, Narod SA, Akbari MR, Lynch HT. Prevalence of PALB2 mutations in the Creighton University Breast Cancer Family Registry. Breast Cancer Research and Treatment. 150: 637-41. PMID 25794774 DOI: 10.1007/S10549-015-3347-X  0.707
2015 Metcalfe KA, Zhong T, Narod SA, Quan ML, Holloway C, Hofer S, Bagher S, Semple J. A prospective study of mastectomy patients with and without delayed breast reconstruction: long-term psychosocial functioning in the breast cancer survivorship period. Journal of Surgical Oncology. 111: 258-64. PMID 25557452 DOI: 10.1002/Jso.23829  0.639
2015 Causarano N, Platt J, Baxter NN, Bagher S, Jones JM, Metcalfe KA, Hofer SO, O'Neill AC, Cheng T, Starenkyj E, Zhong T. Pre-consultation educational group intervention to improve shared decision-making for postmastectomy breast reconstruction: a pilot randomized controlled trial. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 23: 1365-75. PMID 25351455 DOI: 10.1007/S00520-014-2479-6  0.49
2015 Metcalfe KA, Poll A, Llacuachaqui M, Virani S, Nanda S, Sun P, Narod S. Patient-reported outcomes associated with population-based Jewish genetic testing for BRCA1 and BRCA2. Journal of Clinical Oncology. 33: 1531-1531. DOI: 10.1200/Jco.2015.33.15_Suppl.1531  0.704
2015 Visscher K, Metcalfe KA, Semple JL. Breast deformity and reconstruction in Turner syndrome: A collection of case studies Jpras Open. 4: 16-21. DOI: 10.1016/J.Jpra.2015.03.002  0.505
2014 Zhong T, Novak CB, Bagher S, Maass SW, Zhang J, Arad U, O'Neill AC, Metcalfe KA, Hofer SO. Using propensity score analysis to compare major complications between DIEP and free muscle-sparing TRAM flap breast reconstructions. Plastic and Reconstructive Surgery. 133: 774-82. PMID 24675183 DOI: 10.1097/Prs.0000000000000024  0.394
2014 Kotsopoulos J, Metcalfe K, Alston J, Nikitina D, Ginsburg O, Eisen A, Demsky R, Akbari M, Zbuk K, Narod SA. Prospective study of high-risk, BRCA1/2-mutation negative women: the 'negative study'. Bmc Cancer. 14: 221. PMID 24667084 DOI: 10.1186/1471-2407-14-221  0.702
2014 Finch AP, Lubinski J, Møller P, Singer CF, Karlan B, Senter L, Rosen B, Maehle L, Ghadirian P, Cybulski C, Huzarski T, Eisen A, Foulkes WD, Kim-Sing C, Ainsworth P, ... ... Metcalfe KA, et al. Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 1547-53. PMID 24567435 DOI: 10.1200/Jco.2013.53.2820  0.643
2014 Baltzer HL, Alonzo-Proulx O, Mainprize JG, Yaffe MJ, Metcalfe KA, Narod SA, Warner E, Semple JL. MRI volumetric analysis of breast fibroglandular tissue to assess risk of the spared nipple in BRCA1 and BRCA2 mutation carriers. Annals of Surgical Oncology. 21: 1583-8. PMID 24526546 DOI: 10.1245/S10434-014-3532-X  0.594
2014 Metcalfe K, Gershman S, Ghadirian P, Lynch HT, Snyder C, Tung N, Kim-Sing C, Eisen A, Foulkes WD, Rosen B, Sun P, Narod SA. Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis. Bmj (Clinical Research Ed.). 348: g226. PMID 24519767 DOI: 10.1136/Bmj.G226  0.717
2014 Metcalfe KA, Kim-Sing C, Ghadirian P, Sun P, Narod SA. Health care provider recommendations for reducing cancer risks among women with a BRCA1 or BRCA2 mutation. Clinical Genetics. 85: 21-30. PMID 23859469 DOI: 10.1111/Cge.12233  0.68
2014 Pal T, Lee JH, Besharat A, Thompson Z, Monteiro AN, Phelan C, Lancaster JM, Metcalfe K, Sellers TA, Vadaparampil S, Narod SA. Modes of delivery of genetic testing services and the uptake of cancer risk management strategies in BRCA1 and BRCA2 carriers. Clinical Genetics. 85: 49-53. PMID 23438721 DOI: 10.1111/Cge.12130  0.381
2014 Metcalfe KA, Lynch HT, Snyder CL, Foulkes W, Tung NM, Kim-Sing C, Olopade OI, Eisen A, Rosen B, Sun P, Narod S. The impact of oophorectomy on survival after breast cancer in BRCA1 and BRCA2 mutation carriers. Journal of Clinical Oncology. 32: 1507-1507. DOI: 10.1200/Jco.2014.32.15_Suppl.1507  0.734
2013 Zhong T, Hu J, Bagher S, O'Neill AC, Beber B, Hofer SO, Metcalfe KA. Decision regret following breast reconstruction: the role of self-efficacy and satisfaction with information in the preoperative period. Plastic and Reconstructive Surgery. 132: 724e-734e. PMID 24165624 DOI: 10.1097/Prs.0B013E3182A3Bf5D  0.399
2013 Zhong T, Bagher S, Jindal K, Zeng D, O'Neill AC, MacAdam S, Butler K, Hofer SO, Pusic A, Metcalfe KA. The influence of dispositional optimism on decision regret to undergo major breast reconstructive surgery. Journal of Surgical Oncology. 108: 526-30. PMID 24105811 DOI: 10.1002/jso.23437  0.447
2013 Platt J, Baxter N, Jones J, Metcalfe K, Causarano N, Hofer SO, O'Neill A, Cheng T, Starenkyj E, Zhong T. Pre-consultation educational group intervention to improve shared decision-making in postmastectomy breast reconstruction: study protocol for a pilot randomized controlled trial. Trials. 14: 199. PMID 23829442 DOI: 10.1186/1745-6215-14-199  0.382
2013 Metcalfe KA, Poll A, Royer R, Nanda S, Llacuachaqui M, Sun P, Narod SA. A comparison of the detection of BRCA mutation carriers through the provision of Jewish population-based genetic testing compared with clinic-based genetic testing. British Journal of Cancer. 109: 777-9. PMID 23778531 DOI: 10.1038/Bjc.2013.309  0.56
2013 Semple J, Metcalfe KA, Lynch HT, Kim-Sing C, Senter L, Pal T, Ainsworth P, Lubinski J, Tung N, Eng C, Gilchrist D, Blum J, Neuhausen SL, Singer CF, Ghadirian P, et al. International rates of breast reconstruction after prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers. Annals of Surgical Oncology. 20: 3817-22. PMID 23740344 DOI: 10.1245/S10434-013-3040-4  0.712
2013 Pal T, Vadaparampil S, Kim J, Xu Y, Friedman S, Narod SA, Metcalfe K. Interest of individuals from BRCA families to participate in research studies focused on male BRCA carriers. Familial Cancer. 12: 615-9. PMID 23504063 DOI: 10.1007/S10689-013-9624-0  0.543
2013 Metcalfe KA, Quan ML, Eisen A, Cil T, Sun P, Narod SA. The impact of having a sister diagnosed with breast cancer on cancer-related distress and breast cancer risk perception. Cancer. 119: 1722-8. PMID 23400407 DOI: 10.1002/Cncr.27924  0.685
2013 Narod SA, Metcalfe K, Lynch HT, Ghadirian P, Robidoux A, Tung N, Gaughan E, Kim-Sing C, Olopade OI, Foulkes WD, Robson M, Offit K, Jakubowska A, Byrski T, Huzarski T, et al. Should all BRCA1 mutation carriers with stage i breast cancer receive chemotherapy? Breast Cancer Research and Treatment. 138: 273-279. PMID 23381743 DOI: 10.1007/S10549-013-2429-X  0.71
2013 Finch A, Metcalfe KA, Chiang J, Elit L, McLaughlin J, Springate C, Esplen MJ, Demsky R, Murphy J, Rosen B, Narod SA. The impact of prophylactic salpingo-oophorectomy on quality of life and psychological distress in women with a BRCA mutation. Psycho-Oncology. 22: 212-9. PMID 21913283 DOI: 10.1002/Pon.2041  0.51
2013 Baltzer H, Alonzo O, Yaffe M, Narod S, Metcalfe KA, Warner E, Semple J. MRI volumetric analysis of fibroglandular tissue to assess risk of the spared nipple in BRCA 1/2 patients who are considering prophylactic nipple-sparing mastectomy. Journal of Clinical Oncology. 31: 1507-1507. DOI: 10.1200/Jco.2013.31.15_Suppl.1507  0.596
2012 Lam A, Secord S, Butler K, Hofer SO, Liu E, Metcalfe KA, Zhong T. A breast reconstruction needs assessment: How does self-efficacy affect information access and preferences? The Canadian Journal of Plastic Surgery = Journal Canadien De Chirurgie Plastique. 20: 37-42. PMID 23598765 DOI: 10.1177/229255031202000101  0.481
2012 Wong J, D'Alimonte L, Angus J, Paszat L, Metcalfe K, Whelan T, Llewellyn-Thomas H, Warner E, Franssen E, Szumacher E. Development of patients' decision aid for older women with stage I breast cancer considering radiotherapy after lumpectomy. International Journal of Radiation Oncology, Biology, Physics. 84: 30-8. PMID 22331002 DOI: 10.1016/J.Ijrobp.2011.11.028  0.527
2012 Metcalfe KA, Mian N, Enmore M, Poll A, Llacuachaqui M, Nanda S, Sun P, Hughes KS, Narod SA. Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screening. Breast Cancer Research and Treatment. 133: 735-40. PMID 22240989 DOI: 10.1007/S10549-011-1941-0  0.726
2012 Metcalfe KA, Semple J, Quan ML, Vadaparampil ST, Holloway C, Brown M, Bower B, Sun P, Narod SA. Changes in psychosocial functioning 1 year after mastectomy alone, delayed breast reconstruction, or immediate breast reconstruction. Annals of Surgical Oncology. 19: 233-41. PMID 21674270 DOI: 10.1245/S10434-011-1828-7  0.624
2012 Ertmański S, Metcalfe K, Trempała J, Głowacka M, Lubiński J, Narod S, Gronwald J. Identification of patients at high risk of negative psychological consequences associated with BRCA1 mutation Hereditary Cancer in Clinical Practice. 10: A14. DOI: 10.1186/1897-4287-10-S1-A14  0.545
2012 Culver JO, MacDonald DJ, Thornton AA, Sand SR, Grant M, Bowen DJ, Burke H, Garcia N, Metcalfe KA, Weitzel JN. Erratum to: Development and Evaluation of a Decision Aid for BRCA Carriers with Breast Cancer Journal of Genetic Counseling. 22: 406-406. DOI: 10.1007/S10897-012-9513-Y  0.419
2011 Metcalfe K, Gershman S, Lynch HT, Ghadirian P, Tung N, Kim-Sing C, Olopade OI, Domchek S, McLennan J, Eisen A, Foulkes WD, Rosen B, Sun P, Narod SA. Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. British Journal of Cancer. 104: 1384-92. PMID 21487411 DOI: 10.1038/Bjc.2011.120  0.705
2011 Culver JO, MacDonald DJ, Thornton AA, Sand SR, Grant M, Bowen DJ, Burke H, Garcia N, Metcalfe KA, Weitzel JN. Development and evaluation of a decision aid for BRCA carriers with breast cancer. Journal of Genetic Counseling. 20: 294-307. PMID 21369831 DOI: 10.1007/S10897-011-9350-4  0.568
2011 Metcalfe K, Lynch HT, Ghadirian P, Tung N, Kim-Sing C, Olopade OI, Domchek S, Eisen A, Foulkes WD, Rosen B, Vesprini D, Sun P, Narod SA. Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment. 127: 287-96. PMID 21221768 DOI: 10.1007/S10549-010-1336-7  0.73
2011 Finch A, Metcalfe KA, Chiang JK, Elit L, McLaughlin J, Springate C, Demsky R, Murphy J, Rosen B, Narod SA. The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation. Gynecologic Oncology. 121: 163-8. PMID 21216453 DOI: 10.1016/J.Ygyno.2010.12.326  0.663
2011 Brown SM, Culver JO, Osann KE, MacDonald DJ, Sand S, Thornton AA, Grant M, Bowen DJ, Metcalfe KA, Burke HB, Robson ME, Friedman S, Weitzel JN. Health literacy, numeracy, and interpretation of graphical breast cancer risk estimates. Patient Education and Counseling. 83: 92-8. PMID 20554149 DOI: 10.1016/J.Pec.2010.04.027  0.472
2011 Szumacher E, Wong J, D'Alimonte L, Angus J, Paszat L, Metcalfe K, Whelan T, Llewellyn-Thomas H. P5-15-03: Development of a Patient Decision Aid for Women 70 Years and Older with Stage I, Hormonally Sensitive, Breast Cancer Considering Adjuvant Treatment Post-Lumpectomy. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P5-15-03  0.526
2010 Metcalfe K, Lubinski J, Lynch HT, Ghadirian P, Foulkes WD, Kim-Sing C, Neuhausen S, Tung N, Rosen B, Gronwald J, Ainsworth P, Sweet K, Eisen A, Sun P, Narod SA, et al. Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations. Journal of the National Cancer Institute. 102: 1874-8. PMID 21098759 DOI: 10.1093/Jnci/Djq443  0.745
2010 Metcalfe KA, Poll A, Llacuachaqui M, Nanda S, Tulman A, Mian N, Sun P, Narod SA. Patient satisfaction and cancer-related distress among unselected Jewish women undergoing genetic testing for BRCA1 and BRCA2. Clinical Genetics. 78: 411-7. PMID 20653694 DOI: 10.1111/J.1399-0004.2010.01499.X  0.726
2010 Metcalfe KA, Poll A, Royer R, Llacuachaqui M, Tulman A, Sun P, Narod SA. Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 387-91. PMID 20008623 DOI: 10.1200/Jco.2009.25.0712  0.607
2010 Narod SA, Metcalfe KA. Reply to D. Rayson et al Journal of Clinical Oncology. 28: e309-e309. DOI: 10.1200/Jco.2010.29.1146  0.578
2009 Ertmański S, Metcalfe K, Trempała J, Głowacka MD, Lubiński J, Narod SA, Gronwald J. Identification of patients at high risk of psychological distress after BRCA1 genetic testing. Genetic Testing and Molecular Biomarkers. 13: 325-30. PMID 19405874 DOI: 10.1089/Gtmb.2008.0126  0.627
2009 Finch A, Metcalfe K, Lui J, Springate C, Demsky R, Armel S, Rosen B, Murphy J, Elit L, Sun P, Narod S. Breast and ovarian cancer risk perception after prophylactic salpingo-oophorectomy due to an inherited mutation in the BRCA1 or BRCA2 gene. Clinical Genetics. 75: 220-4. PMID 19263514 DOI: 10.1111/J.1399-0004.2008.01117.X  0.705
2009 Esplen MJ, Stuckless N, Hunter J, Liede A, Metcalfe K, Glendon G, Narod S, Butler K, Scott J, Irwin E. The BRCA Self-Concept Scale: a new instrument to measure self-concept in BRCA1/2 mutation carriers. Psycho-Oncology. 18: 1216-29. PMID 19180529 DOI: 10.1002/Pon.1498  0.493
2009 Metcalfe KA. Oophorectomy for breast cancer prevention in women with BRCA1 or BRCA2 mutations. Women's Health (London, England). 5: 63-8. PMID 19102642 DOI: 10.2217/17455057.5.1.63  0.684
2009 Metcalfe KA, Finch A, Poll A, Horsman D, Kim-Sing C, Scott J, Royer R, Sun P, Narod SA. Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation. British Journal of Cancer. 100: 421-5. PMID 19088722 DOI: 10.1038/Sj.Bjc.6604830  0.754
2009 Metcalfe KA, Fan I, McLaughlin J, Risch HA, Rosen B, Murphy J, Bradley L, Armel S, Sun P, Narod SA. Uptake of clinical genetic testing for ovarian cancer in Ontario: a population-based study. Gynecologic Oncology. 112: 68-72. PMID 19019415 DOI: 10.1016/J.Ygyno.2008.10.007  0.661
2008 Metcalfe KA, Foulkes WD, Kim-Sing C, Ainsworth P, Rosen B, Armel S, Poll A, Eisen A, Gilchrist D, Chudley A, Ghadirian P, Maugard C, Lemire EG, Sun P, Narod SA. Family history as a predictor of uptake of cancer preventive procedures by women with a BRCA1 or BRCA2 mutation. Clinical Genetics. 73: 474-9. PMID 18341607 DOI: 10.1111/J.1399-0004.2008.00988.X  0.734
2008 Metcalfe KA, Birenbaum-Carmeli D, Lubinski J, Gronwald J, Lynch H, Moller P, Ghadirian P, Foulkes WD, Klijn J, Friedman E, Kim-Sing C, Ainsworth P, Rosen B, Domchek S, Wagner T, et al. International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. International Journal of Cancer. 122: 2017-22. PMID 18196574 DOI: 10.1002/Ijc.23340  0.742
2008 Metcalfe KA, Lubinski J, Ghadirian P, Lynch H, Kim-Sing C, Friedman E, Foulkes WD, Domchek S, Ainsworth P, Isaacs C, Tung N, Gronwald J, Cummings S, Wagner T, Manoukian S, et al. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 1093-7. PMID 18195327 DOI: 10.1200/Jco.2007.12.6078  0.734
2008 Liede A, Metcalfe K, Offit K, Brown K, Miller S, Narod SA, Moslehi R. A family with three germline mutations in BRCA1 and BRCA2. Clinical Genetics. 54: 215-218. PMID 9788724 DOI: 10.1111/J.1399-0004.1998.Tb04287.X  0.65
2008 Metcalfe K, Finch A, Poll A, Horsman D, Kim-Sing C, Scott J, Royer R, Sun P, Narod S. Abstract B7: Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation Cancer Prevention Research. 1. DOI: 10.1158/1940-6207.Prev-08-B7  0.755
2007 Metcalfe KA, Narod SA. Breast cancer prevention in women with a BRCA1 or BRCA2 mutation. Open Medicine : a Peer-Reviewed, Independent, Open-Access Journal. 1: e184-90. PMID 21673951  0.718
2007 Metcalfe KA, Ghadirian P, Rosen B, Foulkes W, Kim-Sing C, Eisen A, Ainsworth P, Horsman D, Maugard C, Provencher D, Robideaux A, Gilchrist D, Chudley A, Lemire EG, Armel S, et al. Variation in rates of uptake of preventive options by Canadian women carrying the BRCA1 or BRCA2 genetic mutation. Open Medicine : a Peer-Reviewed, Independent, Open-Access Journal. 1: e92-8. PMID 20101300  0.667
2007 Metcalfe KA, Poll A, O'Connor A, Gershman S, Armel S, Finch A, Demsky R, Rosen B, Narod SA. Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation. Clinical Genetics. 72: 208-17. PMID 17718858 DOI: 10.1111/J.1399-0004.2007.00859.X  0.711
2006 Gronwald J, Huzarski T, Byrski T, Debniak T, Metcalfe K, Narod SA, Lubiński J. Direct-to-patient BRCA1 testing: the Twoj Styl experience. Breast Cancer Research and Treatment. 100: 239-45. PMID 16807675 DOI: 10.1007/S10549-006-9261-5  0.698
2006 Lynch HT, Snyder C, Lynch JF, Karatoprakli P, Trowonou A, Metcalfe K, Narod SA, Gong G. Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families. Cancer Genetics and Cytogenetics. 165: 91-7. PMID 16527602 DOI: 10.1016/J.Cancergencyto.2005.07.011  0.678
2005 Snyder C, Lynch JA, Karatoprakli P, Coronel S, Trowonou A, Metcalfe K, Narod SA, Gong G, Lynch HT. Impact of BRCA mutation test results in members of hereditary breast ovarian cancer (HBOC) families. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 1014. PMID 27944917 DOI: 10.1200/Jco.2005.23.16_Suppl.1014  0.664
2005 Metcalfe KA, Foulkes WD, Lynch HT, Ghadirian P, Tung N, Olivotto IA, Warner E, Olopade O, Eisen A, Weber B, McLennan J, Sun P, Narod SA. Effect of Prior Bilateral Oophorectomy on the Presentation of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers. Hereditary Cancer in Clinical Practice. 3: 53-7. PMID 20223030 DOI: 10.1186/1897-4287-3-2-53  0.706
2005 Metcalfe KA, Snyder C, Seidel J, Hanna D, Lynch HT, Narod S. The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation. Familial Cancer. 4: 97-103. PMID 15951959 DOI: 10.1007/S10689-005-4215-3  0.612
2005 Weitzel JN, Robson M, Pasini B, Manoukian S, Stoppa-Lyonnet D, Lynch HT, McLennan J, Foulkes WD, Wagner T, Tung N, Ghadirian P, Olopade O, Isaacs C, Kim-Sing C, Møller P, ... ... Metcalfe K, et al. A comparison of bilateral breast cancers in BRCA carriers Cancer Epidemiology Biomarkers and Prevention. 14: 1534-1538. PMID 15941968 DOI: 10.1158/1055-9965.Epi-05-0070  0.69
2005 Metcalfe KA, Semple JL, Narod SA. Time to reconsider subcutaneous mastectomy for breast-cancer prevention? The Lancet. Oncology. 6: 431-4. PMID 15925821 DOI: 10.1016/S1470-2045(05)70210-2  0.761
2005 Metcalfe KA, Esplen MJ, Goel V, Narod SA. Predictors of quality of life in women with a bilateral prophylactic mastectomy. The Breast Journal. 11: 65-9. PMID 15647082 DOI: 10.1111/J.1075-122X.2005.21546.X  0.472
2005 Metcalfe KA, Lynch HT, Ghadirian P, Tung N, Olivotto IA, Foulkes WD, Warner E, Olopade O, Eisen A, Weber B, McLennan J, Sun P, Narod SA. The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers. Gynecologic Oncology. 96: 222-6. PMID 15589605 DOI: 10.1016/J.Ygyno.2004.09.039  0.723
2005 Esplen M, Hunter J, Leszcz M, Warner E, Narod S, Butler K, Glendon G, Liedem A, Metcalfe K, DiProspero L, Kieffer S, Young M, Irwin E, Wong J. Supportive-expressive group therapy for women with brca1/2mutations: Results of a phase II trial Nursing and Health Sciences. 7: 146-146. DOI: 10.1111/J.1442-2018.2005.00233_12.X  0.581
2004 Esplen MJ, Hunter J, Leszcz M, Warner E, Narod S, Metcalfe K, Glendon G, Butler K, Liede A, Young MA, Kieffer S, DiProspero L, Irwin E, Wong J. A multicenter study of supportive-expressive group therapy for women with BRCA1/BRCA2 mutations. Cancer. 101: 2327-40. PMID 15478194 DOI: 10.1002/Cncr.20661  0.565
2004 Metcalfe KA. Prophylactic bilateral mastectomy for breast cancer prevention. Journal of Women's Health (2002). 13: 822-9. PMID 15385076 DOI: 10.1089/Jwh.2004.13.822  0.662
2004 Metcalfe KA, Semple JL, Narod SA. Satisfaction with breast reconstruction in women with bilateral prophylactic mastectomy: a descriptive study. Plastic and Reconstructive Surgery. 114: 360-6. PMID 15277800 DOI: 10.1097/01.Prs.0000131877.52740.0E  0.693
2004 Metcalfe K, Lynch HT, Ghadirian P, Tung N, Olivotto I, Warner E, Olopade OI, Eisen A, Weber B, McLennan J, Sun P, Foulkes WD, Narod SA. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 2328-35. PMID 15197194 DOI: 10.1200/Jco.2004.04.033  0.712
2004 Menkiszak J, Rzepka-Górska I, Górski B, Gronwald J, Byrski T, Huzarski T, Jakubowska A, Metcalfe KA, Narod SA, Lubiński J. Attitudes toward preventive oophorectomy among BRCA1 mutation carriers in Poland. European Journal of Gynaecological Oncology. 25: 93-5. PMID 15053071  0.647
2004 Foulkes WD, Metcalfe K, Sun P, Hanna WM, Lynch HT, Ghadirian P, Tung N, Olopade OI, Weber BL, McLennan J, Olivotto IA, Bégin LR, Narod SA. Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 2029-34. PMID 15041722 DOI: 10.1158/1078-0432.Ccr-03-1061  0.662
2004 Metcalfe KA, Esplen MJ, Goel V, Narod SA. Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy. Psycho-Oncology. 13: 14-25. PMID 14745742 DOI: 10.1002/Pon.726  0.629
2003 Foulkes WD, Metcalfe K, Hanna W, Lynch HT, Ghadirian P, Tung N, Olopade O, Weber B, McLennan J, Olivotto IA, Sun P, Chappuis PO, Bégin LR, Brunet JS, Narod SA. Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma. Cancer. 98: 1569-77. PMID 14534871 DOI: 10.1002/Cncr.11688  0.543
2003 Metcalfe KA, Liede A, Trinkaus M, Hanna D, Narod SA. Evaluation of the needs of spouses of female carriers of mutations in BRCA1 and BRCA2. Clinical Genetics. 62: 464-9. PMID 12485194 DOI: 10.1034/J.1399-0004.2002.620607.X  0.619
2002 Metcalfe KA, Narod SA. Breast cancer risk perception among women who have undergone prophylactic bilateral mastectomy. Journal of the National Cancer Institute. 94: 1564-9. PMID 12381709 DOI: 10.1093/Jnci/94.20.1564  0.725
2002 Metcalfe KA, Goel V, Lickley L, Semple J, Narod SA. Prophylactic bilateral mastectomy: patterns of practice. Cancer. 95: 236-42. PMID 12124821 DOI: 10.1002/Cncr.10680  0.574
2000 Metcalfe KA, Liede A, Hoodfar E, Scott A, Foulkes WD, Narod SA. An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling. Journal of Medical Genetics. 37: 866-74. PMID 11073541 DOI: 10.1136/Jmg.37.11.866  0.748
2000 Liede A, Metcalfe K, Hanna D, Hoodfar E, Snyder C, Durham C, Lynch HT, Narod SA. Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling. American Journal of Human Genetics. 67: 1494-504. PMID 11063672 DOI: 10.1086/316907  0.702
Low-probability matches (unlikely to be authored by this person)
2015 Finch A, Wang M, Fine A, Atri L, Khalouei S, Pupavac M, Rosen B, Eisen A, Elser C, Charames G, Metcalfe K, Chang MC, Narod SA, Lerner-Ellis J. Genetic testing for BRCA1 and BRCA2 in the Province of Ontario Clinical Genetics. DOI: 10.1111/cge.12647  0.292
2015 McGillion M, Victor JC, Carroll SL, Metcalfe K, O'Keefe-McCarthy S, Jamal N, Arthur HM, McKelvie R, Jolicoeur EM, Hanlon JG, Stone J, Niznick J, Beanlands R, Svorkdal N, Coyte P, et al. The CREATE Method for Expressing Continuous Outcome Data in Absolute Terms for Use in Patient Treatment Decision Aids: A Validation Study. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 35: 959-66. PMID 26246516 DOI: 10.1177/0272989X15598540  0.28
2012 Szumacher E, Wong J, D'Alimonte L, Angus J, Paszat L, Metcalfe K, Whelan T, Llewellyn-Thomas H, Warner E. Development of a Patient Decision Aid for Older Women With Stage I Breast Cancer Considering Adjuvant Treatment Postlumpectomy International Journal of Radiation Oncology*Biology*Physics. 84: S221. DOI: 10.1016/J.Ijrobp.2012.07.573  0.278
2019 Vigod SN, Hussain-Shamsy N, Stewart DE, Grigoriadis S, Metcalfe K, Oberlander TF, Schram C, Taylor VH, Dennis CL. A patient decision aid for antidepressant use in pregnancy: Pilot randomized controlled trial. Journal of Affective Disorders. 251: 91-99. PMID 30913472 DOI: 10.1016/J.Jad.2019.01.051  0.277
2022 McCuaig JM, Stockley TL, Ferguson SE, Vicus D, Brennenstuhl S, Ott K, Kim RH, Metcalfe KA. Patient-reported outcomes associated with reflex BRCA1/2 tumor and subsequent germline panel genetic testing for high-grade serous ovarian cancer. Journal of Genetic Counseling. PMID 36478486 DOI: 10.1002/jgc4.1661  0.276
2023 Wenger R, Retrouvey H, Metcalfe K, Semple JL. Patient Outcomes after Fat Grafting to the Radiated Chest Wall before Delayed Two-stage Alloplastic Breast Reconstruction. Plastic and Reconstructive Surgery. Global Open. 11: e5119. PMID 37448766 DOI: 10.1097/GOX.0000000000005119  0.273
2020 Zhong T, Quong WL, Cheng T, Kerrebijn I, Butler K, Hofer SOP, OʼNeill AC, Cil TD, Metcalfe KA. Preconsultation Educational Group Intervention Can Address the Knowledge Gap in Postmastectomy Breast Reconstruction. Annals of Plastic Surgery. PMID 33252432 DOI: 10.1097/SAP.0000000000002603  0.247
2014 Fan L, Sidani S, Cooper-Brathwaite A, Metcalfe K. Improving foot self-care knowledge, self-efficacy, and behaviors in patients with type 2 diabetes at low risk for foot ulceration: a pilot study. Clinical Nursing Research. 23: 627-43. PMID 23823459 DOI: 10.1177/1054773813491282  0.245
2014 McGillion MH, Carroll SL, Metcalfe K, Arthur HM, Victor JC, McKelvie R, Jolicoeur EM, Lessard MG, Stone J, Svorkdal N, Hanlon JG, Andrade A, Niznick J, Malysh L, McDonald W, et al. Development of a patient decision aid for people with refractory angina: protocol for a three-phase pilot study. Health and Quality of Life Outcomes. 12: 93. PMID 24920518 DOI: 10.1186/1477-7525-12-93  0.243
2013 Fan L, Sidani S, Cooper-Brathwaite A, Metcalfe K. Feasibility, acceptability and effects of a foot self-care educational intervention on minor foot problems in adult patients with diabetes at low risk for foot ulceration: a pilot study. Canadian Journal of Diabetes. 37: 195-201. PMID 24070843 DOI: 10.1016/J.Jcjd.2013.03.020  0.242
2014 Fan L, Sidani S, Cooper-Brathwaite A, metcalfe K. Effects of A Foot Self-Care Educational Intervention on Improving Footwear in Patients with Type 2 Diabetes at Low Risk for Foot Ulceration Canadian Journal of Diabetes. 38: S31. DOI: 10.1016/J.Jcjd.2014.07.226  0.241
2013 Fan L, Sidani S, Cooper-Brathwaite A, Metcalfe K. Feasibility, Acceptability and Effects of a Foot Self-Care Educational Intervention on Minor Foot Problems in Patients with Type 2 Diabetes at Low Risk for Foot Ulceration: A Pilot Study Canadian Journal of Diabetes. 37: S16. DOI: 10.1016/J.Jcjd.2013.08.045  0.238
2015 Mayo SJ, Messner HA, Rourke SB, Howell D, Victor JC, Kuruvilla J, Lipton JH, Gupta V, Kim DDH, McGillis L, Uhm J, Michelis FV, Alam N, Lambie A, Breen D, ... ... Metcalfe K, et al. Predictors of the Trajectory of Neurocognitive Functioning in the First Six Months after Allogeneic Hematopoietic Stem Cell Transplantation Blood. 126: 3289-3289. DOI: 10.1182/Blood.V126.23.3289.3289  0.236
2016 Mayo S, Messner HA, Rourke SB, Howell D, Victor JC, Kuruvilla J, Lipton JH, Gupta V, Kim DD, Piescic C, Breen D, Lambie A, Loach D, Michelis FV, Alam N, ... ... Metcalfe K, et al. Relationship between neurocognitive functioning and medication management ability over the first 6 months following allogeneic stem cell transplantation. Bone Marrow Transplantation. PMID 26926230 DOI: 10.1038/Bmt.2016.2  0.226
2020 Medeiros C, Buckley L, Metcalfe K, Narayanan UG, Widger K. Decision aids available for parents making end-of-life or palliative care decisions for children: A scoping review. Journal of Paediatrics and Child Health. PMID 32281164 DOI: 10.1111/Jpc.14885  0.221
2021 Boghosian T, McCuaig JM, Carlsson L, Metcalfe KA. Psychosocial Interventions for Women with a or Mutation: A Scoping Review. Cancers. 13. PMID 33804884 DOI: 10.3390/cancers13071486  0.21
2019 Mayo SJ, Messner HA, Rourke SB, Howell D, Victor JC, Lipton JH, Kuruvilla J, Gutpa V, Kim DDH, Michelis FV, Metcalfe K. Predictors of the trajectory of cognitive functioning in the first 6 months after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. PMID 31745248 DOI: 10.1038/S41409-019-0746-3  0.205
2015 Semple JL, Sharpe S, Murnaghan ML, Theodoropoulos J, Metcalfe KA. Using a mobile app for monitoring post-operative quality of recovery of patients at home: a feasibility study. Jmir Mhealth and Uhealth. 3: e18. PMID 25679749 DOI: 10.2196/Mhealth.3929  0.199
2017 Balasubramanian M, Willoughby J, Fry AE, Weber A, Firth HV, Deshpande C, Berg JN, Chandler K, Metcalfe KA, Lam W, Pilz D, Tomkins S. Delineating the phenotypic spectrum of Bainbridge-Ropers syndrome: 12 new patients with de novo, heterozygous, loss-of-function mutations in ASXL3 and review of published literature. Journal of Medical Genetics. PMID 28100473 DOI: 10.1136/jmedgenet-2016-104360  0.189
2021 Buick C, Murphy KJ, Howell D, Metcalfe K. Understanding the role of oncogenic human papillomavirus (HPV) status on adherence behaviors among women with abnormal cervical cytology. Bmc Women's Health. 21: 29. PMID 33461543 DOI: 10.1186/s12905-020-01168-2  0.147
2009 Buick C, Metcalfe K. The human papillomavirus vaccine: an oncology nursing issue. Canadian Oncology Nursing Journal = Revue Canadienne De Nursing Oncologique. 19: 60-4. PMID 19757763 DOI: 10.5737/1181912x1926064  0.132
2019 Smith O, Metcalfe K, Puts M, McDonald E, Sue-Chee S, Bessonova S, Faraj Z, Roy P, Friedrich J. 831 Critical Care Medicine. 47: 394. DOI: 10.1097/01.ccm.0000551580.19352.0d  0.12
2023 Panchal S, Mahajan R, Aujla N, McKay P, Casalino S, Di Gioacchino V, Charames GS, Lefebvre M, Metcalfe KA, Akbari MR, McCuaig JM, Lerner-Ellis J. Recontact to return new or updated genetic results in the clinical laboratory setting. Journal of Medical Genetics. PMID 38124008 DOI: 10.1136/jmg-2023-109652  0.117
2022 Hussain-Shamsy N, Somerton S, Stewart DE, Grigoriadis S, Metcalfe K, Oberlander TF, Schram C, Taylor VH, Dennis CL, Vigod SN. The development of a patient decision aid to reduce decisional conflict about antidepressant use in pregnancy. Bmc Medical Informatics and Decision Making. 22: 130. PMID 35562801 DOI: 10.1186/s12911-022-01870-1  0.116
2020 Smith OM, Metcalfe K, Puts M, McDonald E, Sue-Chee S, Friedrich JO. Role Incongruence and Psychological Stress Symptoms in Substitute Decision Makers of Intensive Care Patients. American Journal of Critical Care : An Official Publication, American Association of Critical-Care Nurses. 29: 301-310. PMID 32607568 DOI: 10.4037/ajcc2020307  0.085
2023 Kamboj N, Metcalfe K, Chu CH, Conway A. Predicting Blood Pressure After Nitroglycerin Infusion Dose Titration in Critical Care Units: A Multicenter Retrospective Study. Computers, Informatics, Nursing : Cin. PMID 38112619 DOI: 10.1097/CIN.0000000000001086  0.055
2000 Davies MJ, King TT, Metcalfe KA, Monson JP. Intraventricular craniopharyngioma: a long-term follow-up of six cases. British Journal of Neurosurgery. 11: 533-41. PMID 11013625 DOI: 10.1080/02688699745691  0.052
2008 Moyes VJ, Metcalfe KA, Drake WM. Clinical use of cabergoline as primary and adjunctive treatment for acromegaly. European Journal of Endocrinology. 159: 541-5. PMID 18708434 DOI: 10.1530/EJE-08-0306  0.05
2020 Mayo SJ, Wozniczka I, Brennenstuhl S, Rourke SB, Howell D, Metcalfe KA, Lipton JH. Late cognitive outcomes among allogeneic stem cell transplant survivors: follow-up data from a 6-year longitudinal study. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 32965579 DOI: 10.1007/s00520-020-05761-x  0.044
2004 Carroll PV, Drake WM, Maher KT, Metcalfe K, Shaw NJ, Dunger DB, Cheetham TD, Camacho-Hübner C, Savage MO, Monson JP. Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth. The Journal of Clinical Endocrinology and Metabolism. 89: 3890-5. PMID 15292323 DOI: 10.1210/JC.2003-031588  0.036
1993 Williams DJ, Metcalfe KA, Skingle L, Stock AI, Beedham T, Monson JP. Pathophysiology of transient cranial diabetes insipidus during pregnancy. Clinical Endocrinology. 38: 595-600. PMID 8334746 DOI: 10.1111/j.1365-2265.1993.tb02140.x  0.031
2021 Kamboj N, Chang K, Metcalfe K, Chu CH, Conway A. Accuracy and precision of continuous non-invasive arterial pressure monitoring in critical care: A systematic review and meta-analysis. Intensive & Critical Care Nursing. 103091. PMID 34244028 DOI: 10.1016/j.iccn.2021.103091  0.029
2003 Drake WM, Carroll PV, Maher KT, Metcalfe KA, Camacho-Hübner C, Shaw NJ, Dunger DB, Cheetham TD, Savage MO, Monson JP. The effect of cessation of growth hormone (GH) therapy on bone mineral accretion in GH-deficient adolescents at the completion of linear growth. The Journal of Clinical Endocrinology and Metabolism. 88: 1658-63. PMID 12679453 DOI: 10.1210/JC.2002-021541  0.026
2022 Mayo SJ, Wozniczka I, Edwards B, Rourke SB, Howell D, Metcalfe KA, Taghavi Haghayegh A, Lipton JH. A Qualitative Study of the Everyday Impacts of Cognitive Difficulties After Stem Cell Transplantation. Oncology Nursing Forum. 49: 315-325. PMID 35788736 DOI: 10.1188/22.ONF.315-325  0.022
2001 Metcalfe KA, Hitman GA, Rowe RE, Hawa M, Huang X, Stewart T, Leslie RD. Concordance for type 1 diabetes in identical twins is affected by insulin genotype. Diabetes Care. 24: 838-42. PMID 11347740 DOI: 10.2337/DIACARE.24.5.838  0.016
2006 LUBIŃSKI J, BYRSKI T, GRONWALD J, GÓRSKI B, CYBULSKI C, HUZARSKI T, URBAŃSKI K, MITUŚ J, MARCZYK E, DZIUBA J, WANDZEL P, SURDYKA D, HAUS O, PAMUŁA J, METCALFE K, et al. Postępy w genetyce klinicznej dziedzicznego raka piersi PrzegląD Ginekologiczno-POłOżNiczy. 6: 259-260. DOI: 10.1066/S10014060039  0.01
2004 Hoy LJ, Emery M, Wedzicha JA, Davison AG, Chew SL, Monson JP, Metcalfe KA. Obstructive sleep apnea presenting as pseudopheochromocytoma: a case report. The Journal of Clinical Endocrinology and Metabolism. 89: 2033-8. PMID 15126517 DOI: 10.1210/jc.2003-031348  0.01
Hide low-probability matches.